Namzaric (memantine and donepezil hydrochlorides) Extended-release
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER)
July 2016
WARNINGS AND PRECAUTIONS
Anesthesia
Cardiovascular Conditions
donepezil hydrochloride, (addition of an active...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts
More News: Anesthesia | Anesthesiology | Cardiology | Cardiovascular | Donepezil | Drugs & Pharmacology | Heart | Namenda | Warnings